The molecular basis for the sensitivity of tumor cells to chemopreventive natural food compounds and commonly used chemotherapeutic agents is not well understood, not least because studies are frequently confounded by the diversity among cell lines or rely on experimental protein overexpression. Here we investigated the eects of nbutyrate, a cancer-preventive short-chain fatty acid produced by anaerobic bacteria in the gastrointestinal tract, on the human wild-type p53 and p21 expressing HCT116 colon carcinoma cell line and on HCT116 cells with either p53 or p21 alleles inactivated by homologous recombination. The eects of n-butyrate were then compared with those elicited by cytotoxic drugs and the natural chemopreventive phytoalexin of wine and grapes, resveratrol. We document that physiological concentrations of n-butyrate stimulate p21 expression and induce apoptosis independently of p53, and that the absence of p21 increases apoptosis drastically. The apoptosis is mediated through the mitochondria and is accompanied by mitochondrial proliferation and membrane potential changes. Adriamycin, etoposide, cisplatinum, colcemid and resveratrol induce distinct cellular responses; however, absence of p21 favors apoptosisinduction by adriamycin, etoposide and colcemid. Thus, control of p21 expression may support chemoprevention and certain tumor therapies. Oncogene (2001) 20, 3387 ± 3398.
Introduction
The p53 tumor suppressor is a predominantly nuclear transcription factor, activated by various stresses including the exposure to chemotherapeutic (Jimenez et al., 1999) and chemopreventive agents (Huang et al., 1999; Hsieh et al., 1999) . Activation of p53 entails cell cycle arrest or apoptosis, both detrimental to the uncontrolled growth of tumors; as a result, tumor cells are frequently selected for defects in the p53 pathway. The consequences of p53 activation are mostly mediated through the enhanced expression of cell cycle regulating proteins such as the p21 Waf1/Cip1 (CDKN1A) inhibitor of cyclin-dependent kinases (CDKs) and through a number of pro-apopotic proteins, among them Bax (Miyashita and Reed, 1995) , Noxa (APR) (Oda et al., 2000a) and p53AIP1 (Oda et al., 2000b) acting at the mitochondrial membrane, the cell surface death receptors Fas/APO-1 (Owen-Schaub et al., 1995) and KILLER/DR5 , the IGF-BP3 inhibitor of the IGF-R1 survival receptor (Buckbinder et al., 1995) , the death domain-containing PIDD protein (Lin et al., 2000) , endothelial cell nitric oxide synthase (Mortensen et al., 1999) , the p85 regulator of the phosphatidyl-3-OH kinase involved in oxigen damage-response (Yin et al., 1998) , enzymes that can produce reactive oxigen species (Polyak et al., 1997) , and the plasma membrane protein PERP (Attardi et al., 2000) . Furthermore, p53 itself can be associated with mitochondria in apoptotic cells (Marchenko et al., 2000) .
Since p53 is often activated by natural chemopreventive agents or therapeutic drugs, one might expect that p53-negative tumors are generally less sensitive or even insensitive to these agents, and indeed, therapy resistance has been strongly associated with the loss of p53 function in the mouse (Lowe et al., 1994) . The role of p53 in the response of human tumors to therapy is controversial (for a recent review, see Brown and Wouters (1999) ), although, for instance, the analysis of a large number of human tumor-derived cell lines has suggested a link between p53-status and drug-sensitivity (Weinstein et al., 1997) . In humans, p53 may even protect rather than sensitize tumor cells to certain DNA-damaging agents (for example: Bunz et al., (1999) ).
Apart from chemotherapeutics employed to treat diagnosed neoplasias, several natural chemopreventive food compounds exist that aect preneoplastic and neoplastic tissue through the p53 pathway. The natural phytoalexin resveratrol present in wine and grapes may serve as an example for a compound capable of killing tumor cells in dependence (Huang et al., 1999; Hsieh et al., 1999) or independently of p53 (M Mahyar-Roemer and R Roemer, 2001, submitted). The cancer-preventive eect of dietary ®ber has been attributed in part to the formation of the short-chain fatty acid butyrate by anaerobic bacterial fermentation in the gastrointestinal tract (Cummings, 1981) . Remarkably, although nbutyrate in the millimolar concentrations found under physiological conditions in the colonic lumen seem to be the major fuel for normal colonocytes, the substance can inhibit proliferation, induce apoptosis and stimulate terminal dierentiation in a variety of neoplastic cell types (Heerdt et al., 1994; Barnard and Warwick, 1994; McBain et al., 1997) . Proliferation inhibition is thought to result from the overproduction of the CDK inhibitors p21 Waf1/Cip1 and p27 Kip1 (Litvak et al., 1998; Nakano et al., 1997) ; however, the importance of the CDK inhibitors and of p53 for cell cycle arrest and apoptosis remains unclear, not least because of the genetic and epigenetic dierences among the diverse tumor cell lines used in the various studies. Here we have analysed the eects of the natural chemopreventive agent n-butyrate and of commonly used chemotherapeutic agents on three isogeneic cell lines derived from the human colon carcinoma line HCT116 that dier only in the absence of p53 or p21 through targetted homologous recombination (Bunz et al., 1998; Waldman et al., 1995) .
Results
In a ®rst set of experiments, the eect of n-butyrate, a short chain fatty acid and natural constituent of the colonic lumen with proliferation-inhibitory and dierentiation-stimulatory eects (Heerdt et al., 1994; Barnard and Warwick, 1994) , was studied on a panel of isogenic cell lines derived from the human mismatchrepair defective HCT116 colon carcinoma cell line. The HCT116 p537/7 cells and HCT116 p217/7 cells were developed from the parental cell line by targetted homologous recombination (Bunz et al., 1998; Waldman et al., 1995) . HCT116 cells are poorly dierentiated and growth-factor insensitive yet responsive to a variety of stresses including DNA-damage and spindle disruption (Wang et al., 1999a; Bunz et al., 1998) . A prime mediator of stress response is the p53 tumor suppressor which is wild-type in HCT116 cells and is stabilized and activated as a transcription factor upon stress (Bunz et al., 1999) . To study whether nbutyrate aects the stability of p53 and the activation of the major p53 target gene p21, HCT116 cells were either mock-treated, treated with 2 mM n-butyrate or, as a control, with 10 mM etoposide and were analysed by immunoblotting at dierent time points. Mocktreated, exponentially growing cells contained only low levels of p53 and p21. Etoposide, like ADR and 5-FU (Bunz et al., 1999) , induced a strong and rapid increase in the steady-state level of p53, visible as early as 3 h after treatment and further accumulating for 24 h whereas n-butyrate failed to trigger p53 accumulation ( Figure 1a ). As expected, the stabilization of p53 following etoposide treatment was accompanied by an increase in the level of p21, indicating the activation of p53 as a transcription factor. Remarkably, the p21 level rose also following n-butyrate exposure, reaching a maximum at around 12 h, although p53 remained at background levels ( Figure 1a) .
Previous work has indicated that accumulation of p53 and its activation as transcription factor can be separate events (Hupp and Lane, 1994) . On the other hand, p21 expression can be stimulated through p53-independent pathways (for instance Huang et al., 2000) . To discriminate whether the rise in p21 upon n-butyrate treatment is caused by active p53 expressed at background levels or through p53-independent mechanisms, HCT116 cells and their p53-and p21-de®cient derivatives were exposed to the drug and, as a further control, to 5-FU. 5-FU is a strong stimulator of p53 accumulation and activity (Bunz et al., 1999) . Figure 1b shows that n-butyrate present for 12 h induces p21-expression to approximately equal levels in the parental and p53-negative cells. Furthermore, the basal level of p53 is elevated in mock-treated p21-negative cells when compared with mock-treated HCT116 cells; however, the p53 level can still be increased by 5-FU treatment. In contrast, n-butyrate fails to elevate the p53 level in either cell line. Thus, nbutyrate induces p21 overproduction independently of p53 and has no detectable eect on p53 activity or stability in human HCT116 colon carcinoma cells.
Butyrate acts pleiotropic in that it modi®es the membrane, cytoskeleton, cell cycle, gene transcription and nuclear factors regulating gene expression (Schwartz et al., 1992; Nakano et al., 1997; Archer et al., 1998) . Physiological concentrations in the millimolar range suce to suppress cell proliferation in vitro and colon cancer progression in a rodent model (Heerdt et al., 1994; Barnard and Warwick, 1994; Boa et al., 1992) . When HCT116 cells were exposed to 2 mM n-butyrate, nuclear condensation evidenced by DAPI staining and microscopic analysis, and DNA breakdown indicative of apoptosis become visible as early as 12 h after the beginning of treatment (data not shown). To quantify apoptosis and to examine the in¯uence of p53 and p21, HCT116 cells and their derivatives were treated with the drug for 24, 48 and 72 h, and the ®xated and propidium iodide-stained cells were analysed by¯ow cytometry. Cells containing less than 2 n DNA are apoptotic. n-butyrate induced cell death in all three cell lines (Figure 2a ). The extent of drug-induced apoptosis was approximately equal in the parental HCT116 cells and the p53-negative derivatives (Figure 2b ). In the p21-negative cultures however, signi®cantly more apoptosis was detected during the entire time course, with more than 60% apoptotic cells after 24 h in contrast to only 20 ± 30% dead cells in the HCT116 and p537/7 cultures. Simultaneously, the numbers of cells with a 2 n or 4 n DNA content decreased strongly in the p217/7 cultures whereas, in contrast, the 2 n DNA peak decreased only slightly and the 4 n DNA peak remained essentially unchanged in both HCT116 and p537/7 cultures (Figure 2a) . Combined, this indicates that n-butyrate induces apoptosis independently of p53 p53 and p21 influence chemosensitivity M Mahyar-Roemer and K Roemer and that p21 exerts a protective eect against apoptotic death in HCT116 cells, probably through the establishment of a cell cycle checkpoint . If p21 is indeed protective, restoration of p21 expression in the p217/7 cells should increase cell survival. To test this, p217/7 cultures were transiently co-transfected with (i) the green¯uorescent protein-expressing plasmid pEGFP-C1 to identify transfected cells plus (ii) either empty vector or plasmid pCMV-p21 demonstrated to produce p21Waf/Cip1. Cultures were then mock-treated or treated with 2 mM n-butyrate and were analysed for apoptosis at 48 h after treatment. Consistent with p21 being protective, cell survival was greatly increased in the subpopulation of cells transfected with pEGFP-C1 and pCMV-p21 ( Figure 2c ). Simultaneous treatment of HCT116 p217/7 cells with n-butyrate and the pan-caspase inhibitor z-VAD-fmk resulted in less apoptosis (Figure 2d ), con®rming that the cell death following n-butyrate exposure is indeed an apoptotic one that involves caspase activity. The mitochondrial (MT) mass is tightly regulated in cells; however, we and others have observed that in several instances of drug-induced tumor cell apoptosis the MT mass as determined by mitochondrial¯uores-cence probes increases at relatively early times following apoptosis induction (Cupler et al., 1995; Reipert et al., 1995; M Mahyar-Roemer and K Roemer, 2001, submitted) . Furthermore, the`mitochondrion' form of apoptosis as opposed to thè receptor-mediated' form is often, but not always, associated with the dissipation of the mitochondrial transmembrane potential DCm as the result of a leakiness of the inner mitochondrial membrane (Kroemer and Reed, 2000; Green and Reed, 1998) . To study the eect of n-butyrate on the MT mass and DCm changes, the cells were stained with the Jaggregate forming lipophilic cation JC-1 which associates with mitochondria as a red¯uorescence lightemitting monomer but turns into a green¯uorescence light-emitting dimer in a reaction driven by the membrane potential. Treatment of the cultures with 2 mM n-butyrate entailed an increase of the MT mass relative to mock-treated cultures by a factor of 1.5 ± 3.0 within 72 h (Figure 3a ,b). The MT mass increase was strongest in the HCT116 p217/7 cultures, whereas Figure 1 Eect of n-butyrate on the steady state levels of p53 and p21. (a) Accumulation of p53 upon etoposide but not n-butyrate exposure, and accumulation of p21 upon treatment with either agents. HCT116 cells were mock-treated or treated with the indicated quantities of n-butyrate or etoposide. Protein extracts were prepared at dierent time points and were subsequently subjected to SDS ± PAGE on a 12% gel and to immunoblot analysis with p53-antibody DO-1 at a 1 : 1000 dilution, b-actin antibody (1 : 5000) and p21-antibody (1 : 1000). (b) Independence of the n-butyrate-induced p21 accumulation on p53. HCT116 cells and the p53-and p21-de®cient derivatives were either mock-treated (C) or exposed to 2 mM n-butyrate (b) or 5-FU (375 mM) as control. After 12 h protein extracts were prepared and analysed by immunoblotting Figure 2 n-Butyrate-induced apoptosis in dependence on p53 and p21. (a) Representative¯ow cytometry analysis of the DNA content of ®xated and PI-stained HCT116, p537/7 and p217/7 cells at 48 h after mock-treatment (upper white diagrams) or nbutyrate-treatment (2 mM; lower black diagrams). Note the increase in the number of cells with a less than 2 n DNA content indicative of apoptosis in the lower diagrams (¯uorescence: 510 2 ) and the changes in the 2 n and 4 n DNA peaks (the left and right major peaks, respectively). (b) Quanti®cation of apoptosis following n-butyrate treatment of the three isogenic cell lines for 24, 48 and 72 h. (c) Restoration of p21 expression in the p217/7 cell line. Cells were Eectene-transfected with (i) 0.2 mg of pEGFP-C1 expressing green¯uorescent protein and (ii) 0.2 mg of either empty vector or pCMV-p21 producing p21Waf/Cip1. At 24 h after transfection, the cultures were mock-treated or treated with 2 mM n-butyrate (n-but) and were analysed for apoptosis after 48 h. (d) HCT116 p217/7 cultures were treated with n-butyrate (2 mM) and simultaneously with increasing concentrations (mM) of the pancaspase inhibitor z-VAD-fmk. Apoptosis was analysed 48 h later. Standard deviations were derived from three experiments p53 and p21 influence chemosensitivity M Mahyar-Roemer and K Roemer the least MT mass increase was observed with the HCT116 p537/7 cells. The cause of these dierences is unclear; however, they correlate with the quantities of apoptosis observed following drug treatment of the respective cultures (Figure 2 ). Electron micrographs suggest that the MT mass increase was primarily caused by mitochondrial number increase and not volume increase and is thus the result of mitochondrial proliferation (not shown). As a further control for the relative increase in MT mass upon butyrate treatment, cultures were also stained with the novel mitochondrion-speci®c dye Mito Tracker Green (Molecular Probes), with similar results (Figure 3b ). The examination of DCm by plotting the quotient of JC-1 red versus green¯uorescence light emission revealed changes of the membrane potential during the 72 h time period of n-butyrate treatment in all three cell lines. The most obvious change was an early increase in DCm and a later decrease of the membrane potential to or slightly below the level of the mocktreated controls (Figure 3c ). Transient increases in DCm have been associated with forms of apoptosis in which the inner MT membrane remains largely intact and the outer MT membrane disrupts Kroemer and Reed, 2000) . In summary, the results show that the apoptotic death of HCT116 cells following n-butyrate treatment is p53-independent, inhibited by p21, and accompanied by mitochondrial proliferation and complex DCm changes.
To test whether the anti-apoptotic eect of p21 in HCT116 cells is a more general phenomenon, we carried out a series of experiments in which we exposed the cell lines for dierent times to the chemotherapeutic drugs adriamycin (ADR), etoposide, and cisplatinum, to the spindle toxin colcemid, and to the chemopreventive ingredient of grapes and wine, resveratrol. The eects of these agents (and of n-butyrate for comparison) after 48 h and in dependence of p53 and p21 are summarized in Figure 4 . Several distinct types of responses can be discriminated. First, ADR and etoposide induced very little cell death (less than 5% of the cell population) in the parental HCT116 cells in contrast to colcemid, cisplatinum, n-butyrate and resveratrol which induced cell death at a much higher Figure 3 Mitochondrial changes following n-butyrate treatment. (a) Representative¯ow cytometry analysis of the relative mitochondrial mass as determined by JC-1 green¯uorescence in mock-treated (white) and n-butyrate-treated (2 mM; black) HCT116, p537/7 and p217/7 cells at 12 h after the beginning of treatment. (b) Quanti®cation of the mitochondrial mass increase following n-butyrate exposure of the three isogenic cell lines for 24, 48 and 72 h. As a further measure for MT mass, the novel mitochondrion-speci®c dye Mito Tracker Green (MT-Green) was employed (bar diagram) and the relative increase in MT mass was determined at 48 h after butyrate treatment. (c) Changes in the ratio of JC-1 red versus green¯uorescence as an indicator for changes in the mitochondrial membrane potential DCm over a time course of 72 h. Again, the cells were either mock-treated or treated with 2 mM n-butyrate, and standard deviations were derived from three experiments. The symbols are the same as in (b) rate (20 ± 40%). Second, ADR and etoposide caused more apoptosis in the absence of p53, suggesting that p53 possesses a limited protective eect against these chemotherapeutics. Third and in contrast to these observations, cisplatinum and colcemid induced less apoptosis in the absence of p53, indicating that these death pathways are in part p53-dependent. Fourth and notably, chemosensitivity against ADR, etoposide and colcemid was substantially increased in the absence of p21, as it was against n-butyrate. p21 had no eect on the chemosensitivity against cisplatinum.
Finally, apoptosis by resveratrol was neither aected by p53 nor by p21. Although both ADR and etoposide caused the accumulation of cells with a 4 n DNA content regardless of p53, a fraction of the cultures arrested with a 2 n DNA content only in the presence of p53 ( Figure 4b) ; thus, the limited protective eect of p53 against ADR and etoposide may re¯ect the ability of the tumor suppressor to establish a cell cycle checkpoint (Bunz et al., 1999) . Table 1 summarizes the eects of the dierent drugs on the distribution of HCT116, p537/7 and p217/7 cells in cell cycle.
Treatment of HCT116 cells with ADR (Bunz et al., 1999 and data not shown) or etoposide (Figure 1a ) results in the accumulation and activation of p53, but the vast majority of the cells survive. On the other hand, both agents can trigger apoptosis in the absence of p53 (Figure 4a ). Since there are no p53/p21 double knockout cells, it is unclear whether the dramatic apoptosis seen in the p217/7 line is dependent on p53 or not. To address this point, two sets of experiments were performed. First, HCT116 p217/7 cultures and, as a control, p537/7 cultures were transiently cotransfected (i) with a reporter plasmid expressing green uorescence protein to identify successfully transfected cells in the¯ow cytometer, plus (ii) with either empty vector as control or vector producing the dominantnegative p53-mutant 175H known to inactivate endogenous wild-type p53. The expression of transfected 175H was con®rmed by immunoblotting (Figure 5b) . The cultures were then mock-treated or treated with ADR or etoposide for 24, 48 or 72 h and analysed by FACscan. In the second experiment, endogenous p53 was inhibited by the recently discovered low molecular weight chemical compound pi®thrin-a (30 mM) (Komarov et al., 1998). 
ADR, adriamycin; eto, etoposide; cis, cisplatinum; col, colcemide; res, resveratrol; n-but, n-butyrate. a At 500 ng/ml relative to mocktreated cells. no=no detectable dierences in the FACS pro®les when compared with mock-treated cultures. Cell cycle analysis was performed as outlined in Materials and methods p53 and p21 influence chemosensitivity M Mahyar-Roemer and K Roemer
Overexpression of 175H consistently reduced ADR and etoposide-induced apoptosis in the p217/7 cultures by 20 ± 40% after 72 h (Figure 5a) , consistent with the mutant protein inactivating endogenous wt p53 via its dominant-negative function. We have recently documented that endogenous wt p53 can be blocked by 175H under these experimental conditions (Atz et al., 2000) . However, strongly overproduced 175H may exert an anti-apoptotic`gain-of-function' that is independent of wt p53 (Blandino et al., 1999) . Thus, the observed eect could have been the result of this novel function rather than the dominant-negative function. To test for an anti-apoptotic gain-of-function of 175H, p537/7 cells were transiently transfected with 175H vector or control vector and were exposed to ADR and etoposide which can induce p53-independent apoptosis (Bunz et al., 1999 and Figure 4) . No protective eect of 175H was observed under these conditions; rather, the mutant seemed to even slightly sensitize the cells to apoptosis (Figure 5a ). Of further note in this context, Blandino et al. (1999) observed anti-apoptotic gain-of-function only at very high expression levels of the mutant protein. Such levels were not attained in the majority of the cells with our transfection procedure. Therefore, the anti-apoptotic eect of 175H is likely the result of dominantnegative action.
The eect of pi®thrin-a on ADR and etoposideinduced HCT116 cell death was more subtle. As expected (Komarov et al., 1998) , the drug failed to inhibit p53 accumulation in the parental HCT116 cells upon ADR and etoposide treatment and reduced the expression of the p53 target gene p21 to background levels in the etoposide-treated cultures, indicating the functional inactivation of p53. However, p21 accumulation was not aected in the ADR-treated cultures (Figure 5b ). In accord with these ®ndings, pi®thrin-a inhibited apoptosis by approximately 30% only in the p217/7 cultures exposed to etoposide but not in the cultures exposed to ADR. The reasons for these dierences are unclear. We interpret the data to suggest that the massive apoptosis in p217/7 cells treated with ADR or etoposide is at least in part p53-dependent.
Discussion
The gene for the cyclin-dependent kinase inhibitor p21 is a transcriptional target of p53. p21 overproduction is essential for the damage-induced, p53-mediated G1 cell cycle arrest as well as for a sustained G2 arrest of human tumor cells Bunz et al., 1998) . Nevertheless, p21 expression can be stimulated by a variety of transcriptional activators other than p53 that are often associated with growth arrest and dierentiation, among them MyoD (Halevy et al., 1995) , STAT1 (Chin et al., 1995) and BRCA1 (Somasundaram et al., 1997) . Another way of p53-independent activation of p21 seems to involve histone hyperacetylation through the noncompetitive inhibition of histone deacetylase enzymes by n-butyrate (Archer et al., 1998) which might allow, for instance, two overlapping binding sites in the p21 promoter to be accessed by SP1 or SP1-related transcription factors (Nakano et al., 1997) . Using the set of isogenic human MIN colon carcinoma cell lines consisting of HCT116 cells wild-type for both p53 and p21, and of two derivatives with knocked-out p53 or p21 alleles (Bunz et al., 1998; Waldman et al., 1995) , we showed that physiological concentrations of n-butyrate can stimulate p21 expression with immediate-early kinetics and independently of p53 to levels comparable to those obtained upon treatment with adriamycin, the topoisomerase II inhibitor etoposide and the DNA and RNA-damaging agent 5-FU.
p21 is a vital component of two cell cycle checkpoints Bunz et al., 1998) . Previous work has established a role as a suvival factor for p21 by demonstrating that a defective p21 response can lead HCT116 cells exposed to DNA damaging drugs or radiation to undergo illegitimate DNA replication and to ultimately suer apoptotic death instead of a transient cell cycle arrest Bunz et al., 1999; Polyak et al., 1996) . A large number of studies has since been undertaken to address in which cellular systems and against which insults p21 can be protective. We have shown here that n-butyrate, which is the product of anaerobic bacterial ®ber fermentation within the colon and is thought to be the critical link between a high-®ber diet and a decreased incidence in colon cancer (McIntyre et al., 1993) , is an eective inducer of apoptosis in HCT116 and p537/7 cells, and is even more eective in the absence of p21 (at 2 mM). This stands in some contrast to other studies. McBain et al. (1997) have reported a high level resistance of HCT116 cells to n-butyrateinduced apoptosis and have observed instead a reversible growth inhibition under 5 mM n-butyrate. Along the same line, Archer et al. (1998) have suggested that apoptosis may not be the cause of the observed growth inhibition by n-butyrate in HT-29 and HCT116 cultures. The reasons for these variant results are not clear. Butyrate has been demonstrated to induce signs of dierentiation in colonic cells (Heerdt et al., 1994; Hodin et al., 1996; Litvak et al., 1998; Barshishat et al., 2000) and dierentiation often seems to accompany or even precede apoptotic cell death following exposure to n-butyrate (Heerdt et al., 1994; Litvak et al., 1998) or exposure to the natural chemopreventive phytoalexin resveratrol (M MahyarRoemer and K Roemer, 2001, submitted). We have observed the formation of a microvillar brush border and the expression of the microvillar structural protein villin in n-butyrate-treated HCT116 cells, both indicators of terminal dierentiation (data not shown). Dierentiation and apoptosis may, however, be in¯uenced by the culture conditions. McBain et al. (1997) cultured HCT116 cells in Dulbecco's modi®ed medium whereas this study used McCoy's 5A medium. Furthermore, it has been suggested that the colon cancer cells detached from the culture dish rather than Figure 5 Eects of the inhibition of endogenous wild-type p53 on drug-induced apoptosis in the p21-negative HCT116 cells. (a) p217/7 cells were seeded in 12-well dishes to approximately 30% con¯uency at 24 h prior to drug-exposure, and were Eectene-transfected at 12 h before drug-treatment with (i) 0.2 mg of pEGFP-C1 expressing green¯uorescent protein and (ii) 0.2 mg of either empty expression vector or pCMV-175H producing the dominant-negative p53-mutant 175H. The following day, the cultures received mock-treatment, ADR (0.34 mM) or etoposide (eto; 10 mM). At the indicated time points, the cultures were harvested and the population of successfully transfected cells with green¯uorescence were analysed for DNA content and cell size by¯ow cytometry. Very small cells and cells with a sub-2 n DNA content were de®ned as apoptotic. The bar diagram shows HCT116 p537/7 cells transfected like the p217/7 cells, either untreated or treated with ADR or etoposide and analysed for apoptosis at 48 h after treatment. Note that mutant 175H fails to protect from apoptosis. The standard deviations were derived p53 and p21 influence chemosensitivity M Mahyar-Roemer and K Roemer the adherent ones are the preferred targets of druginduced apoptosis (Heerdt et al., 1994; Archer et al., 1998) . However, we employed here exponentially growing cultures seeded at low to intermediate density with only few detached cells (usually 510%) in the mock-treated dishes, yet observed at least 20% apoptotic cells as early as 24 h after drug treatment.
Terminal dierentiation preceding apoptotic death has been observed in human colon carcinoma cells following treatment with the tyrosine kinase inhibitors herbimycin and genistein (Mancini et al., 1997) or with resveratrol (M Mahyar-Roemer and K Roemer, 2001, submitted) . Remarkably, these changes were accompanied by, and closely correlated with, a mitochondrial mass increase as the result of mitochondrial proliferation. Whether these eects are a prerequisite for some forms of drug-induced apoptosis, and how mitochondrial proliferation is controlled, remains to be studied. However, damage-or p53-induced apoptosis often involves temporary or permanent leakage of the inner mitochondrial membrane with the consequence of DCm collapse . We found no pronounced membrane potential collapse during nbutyrate-induced apoptosis, in accord with forms of cell death in which inner membrane permeability and DCm dissipation are absent or only transient events (Kroemer and Reed, 2000) . Nevertheless, an early and temporary increase of DCm indicative of mitochondrial swelling and disruption of the outer mitochondrial membrane (Vander Heiden et al., 1997) was detected in n-butyrate-treated HCT116 cells and their p53-and p21-negative derivatives.
p21 protecting cells from death following anticancer treatments has been documented in many dierent cell types and by many studies. Absence or reduced expression of the CDK inhibitor supported apoptosis under adriamycin, camptothecin, etoposide, g-irradiation, prostaglandin A2 or p53 overexpression in vitro Polyak et al., 1996; Gorospe et al., 1996 Gorospe et al., , 1997 and in vivo (Waldman et al., 1997; Tian et al., 2000) . Conversely, p21 overproduction through inducible expression systems or adenoviral gene transfer was protective against various insults (Wang et al., 1999b; Gorospe et al., 1996 Gorospe et al., , 1997 . The results presented here con®rm these ®ndings in a set of isogenic cell lines and show that the protective eect of p21 can be functional regardless of whether apoptosis or p21-expression are regulated through p53 or other pathways (Figure 6 ). On the other hand, the protective eect of endogenous p21 is not universal. 5-FU activates p53 and stimulates p21 expression, yet the latter fails to detectably protect against p53-mediated apoptosis (Bunz et al., 1999 and Figures 1b and 4a) . The strong apoptosis induced by physiological concentrations of the cancer-preventive compound in wine and grapes, resveratrol, seems to be neither aected by endogenous p53 nor p21. Likewise, p21 failed to protect cells against the tubulin-aggregating chemotherapeutic agent taxol (Wang et al., 1999b) . Not least, the eect of cisplatinum on HCT116 cells is controversial. While we found that cisplatium, like 5-FU (Bunz et al., 1999) , stimulates apoptosis in dependence of p53 and not in¯uenced by p21, Fan et al. (1997) have reported the opposite. Of note, the authors used in their study HCT116 cells rendered functionally p53-negative by stable overexpression of the p53-degrading protein E6. The disparity between the results may thus re¯ect other eects of pleiotropic E6 protein. The presented ®ndings may help increase the ecacy of preventive and therapeutic compounds.
Materials and methods
Cell culture, plasmids and chemicals HCT116 cells and the p53-and p21-negative derivatives (Bunz et al., 1998; Waldman et al., 1995) were cultured as monolayers at 378C and in a humidi®ed 7% CO 2 atmosphere in McCoy's 5A medium supplemented with 10% FCS. pEGFP-C1 is a plasmid expressing green¯uorescence protein. pCMV-175H contains the gene for the human p53-mutant 175H and pCMV-p21 produces p21Waf/Cip1 under the control of the CMV promoter. pCMV-pA is the empty vector. The plasmids were transfected with the Eectene transfection reagent from QIAGEN (Hilden, Germany). nButyrate, etoposide, ADR, 5-FU, cisplatinum, and propidium iodide (PI) were from Sigma (St. Louis, USA). Resveratrol and pi®thrin-a was purchased from Alexis Biochemicals (San Diego, USA). JC-1 and Mito Tracker Green were obtained from Molecular Probes (Eugene, USA). The p53 monoclonal antibody DO-1 and the caspase inhibitor z-VAD-fmk were from Calbiochem (San Diego), the p21 monoclonal from Transduction Laboratories/PharMingen (San Diego), and the b-actin monoclonal from Sigma. Stock solutions of etoposide, resveratrol, pi®thrin-a, z-VAD-fmk, and Mito Tracker Green were prepared in DMSO; JC-1 was dissolved in methanol and the remaining agents were dissolved in water.
Flow cytometry analysis of DNA content and apoptosis
Cells were seeded in 6-well dishes to approximately 30% con¯uency 1 day prior to drug treatment. At various times, the asynchronously growing cultures were harvested by trypsinization, combined with the cells¯oating in the medium, washed in PBS, resuspended in 200 ml of 0.9% from three experiments. (b) 175H expression following transfection and the eect of pi®thrin-a on the accumulation of p53 and p21 in the parental HCT116 cells. HCT116 cells lacking p21 or p53 were transfected as outlined in (a) with vector-only (V) or pCMVp21. P53 expression (endogenous plus 175H) and b-actin were analysed with p53 and b-actin monoclonals at 48 h after transfection. HCT116 cultures were mock-treated (C), treated with ADR or etoposide (eto), or treated with 30 mM pi®thrin-a in addition to the drugs, beginning at 1 h before drug treatment. After 12 h, protein extracts were prepared and analysed by SDS ± PAGE and immunoblotting with p53-, b-actin and p21 monoclonal antibodies. (c) Representative¯ow cytometry analyses showing the eect of pi®thrin-a on the frequency of cells with a sub-2 n DNA content in ADR-and etoposide-treated p217/7 cultures. The numbers indicate the percentage of apoptosis observed after 48 h NaCl, squeezed through a 23.5 Gauge needle into 1.8 ml of methanol and ®xated for 30 min at 7208C. After repeated washes in PBS, the cells were resuspended in PBS supplemented with RNase A (25 mg/ml) at approximately 10 6 cells per ml, and were stained with PI (25 mg/ml) for several hours at 48C. The DNA¯uorescence was measured using a Beckton Dickinson FACScan (Bedford, USA); data acquisition and analysis was performed with the Cell Quest software from Beckton.
Immunoblot analysis
Cells were seeded in 10 cm dishes to approximately 50% con¯uency 24 h before drug treatment. At the appropriate time points, the cells were lysed in 150 ml of a lysis buer heated to 858C and containing 50 mM Tris-HCl (pH 6.8), 100 mM DTT, 2% SDS, and 20% glycerol. Samples containing 15 mg of total cellular protein were subjected to 8 or 12% SDS ± PAGE and transferred to a nitrocellulose membrane (Immobilon-P, Millipore, Bedford, USA). For signal detection, the membranes were incubated overnight with p53 antibody DO-1 (1 : 1000), p21 antibody (1 : 1000), and b-actin antibody (1 : 5000). Finally, they were incubated with a peroxidase-conjugated anti-mouse antibody and the complexes were visualized with the Renaissance Enhanced Luminol Reagents (NEN, Boston, USA).
Mitochondrial mass and membrane potential
The relative mitochondrial mass was determined by¯ow cytometry using 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1, Molecular Probes) at 10 mg/ml, analysed for green¯uorescence. JC-1 allows the simultaneous analysis of mitochondrial mass (green¯uores-cence) and mitochondrial membrane potential DCm (red/ green¯uorescence). For mitochondrial mass and DCm analysis, 2610 5 cells were trypsinized, resuspended in McCoy's 5A medium supplemented with 0.2% FCS and JC-1, and incubated at 378C for 30 min. The observation wavelenghts were 530 nm for green¯uorescence and 585 nm for red¯uorescence. Figure 6 Diagram summarizing the dierent responses of HCT116 cells to chemotherapeutic and natural chemopreventive agents. The establishment of a p21-dependent cell cycle arrest following treatment with 5-FU or cisplatinum is unclear since p21-independent cell cycle arrests are superimposed p53 and p21 influence chemosensitivity M Mahyar-Roemer and K Roemer
